World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
93
Citations
36057
World Ranking
959
National Ranking
528

Medicine

D-Index
93
Citations
36191
World Ranking
10786
National Ranking
5549

John L. Sullivan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John L. Sullivan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 270 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John L. Sullivan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John L. Sullivan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

John L. Sullivan is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research primarily spans the field of Social Sciences, with particular focus on Communication, Sociology and Political Science, and Literature and Literary Theory.

The main topics of their work include Social Media and Politics, Media Studies and Communication, Digital Marketing and Social Media, Radio, Podcasts, and Digital Media, as well as Literature, Film, and Journalism Analysis.

The recent papers authored by John L. Sullivan are:

  • Audiences (2020), published in The Blackwell Encyclopedia of Sociology
  • GET WITH THE PROGRAM: PROGRAMMATIC ADVERTISING AND THE DATAFICATION OF PODCAST AUDIENCES (2023), published in AoIR Selected Papers of Internet Research

Frequent publication venues for their work include:

  • The Blackwell Encyclopedia of Sociology
  • AoIR Selected Papers of Internet Research

There are no frequently listed co-authors associated with their publications in the provided data.

In 2013, John L. Sullivan was recognized as a Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

    Wenhui Li;Michael J. Moore;Natalya Vasilieva;Jianhua Sui

  • Changes in thymic function with age and during the treatment of HIV infection

    Daniel C. Douek;Richard D. McFarland;Phillip H. Keiser;Earl A. Gage

  • Severe herpesvirus infections in an adolescent without natural killer cells.

    Christine A. Biron;Kevin S. Byron;John L. Sullivan

  • Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

    Frank Kirchhoff;Thomas C. Greenough;Doreen B. Brettler;John L. Sullivan

  • Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

    Rhoda S. Sperling;David E. Shapiro;Robert W. Coombs;John A. Todd

  • Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

    D D Richman;D Havlir;J Corbeil;D Looney

  • Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

    Antonia Kwan;Roshini S. Abraham;Robert Currier;Amy Brower

  • Clinical Spectrum of Lymphoproliferative Disorders in Renal Transplant Recipients and Evidence for the Role of Epstein-Barr Virus

    Douglas W. Hanto;Glauco Frizzera;David T. Purtilo;Kiyoshi Sakamoto

  • Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

    Mark E. Sharkey;Ian Teo;Thomas Greenough;Natalia Sharova

  • Proposed definitions for in utero versus intrapartum transmission of HIV-1.

    Y J Bryson;K Luzuriaga;J L Sullivan;D W Wara

  • Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

    Alejandro Dorenbaum;Coleen K. Cunningham;Richard D. Gelber;Mary Culnane

  • A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

    Dhayendre Moodley;Jagidesa Moodley;Hoosen Coovadia;Glenda Gray

  • High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection

    Diane Havlir;Sarah H. Cheeseman;Margaret Mclaughlin;Robert Murphy

  • Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo

    Donna Hochberg;Jaap M. Middeldorp;Michelle D. Catalina;John L. Sullivan

  • Infectious mononucleosis.

    Unknown

  • ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.

    L A Pinto;J Sullivan;J A Berzofsky;M Clerici

  • Deficient natural killer cell activity in x-linked lymphoproliferative syndrome

    John L. Sullivan;Kevin S. Byron;Frank E. Brewster;David T. Purtilo

  • Frequency of 'Chronic Active Epstein-Barr Virus Infection' in a General Medical Practice

    Dedra Buchwald;John L. Sullivan;Anthony L. Komaroff

  • High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.

    Roberto Mariani;Frank Kirchhoff;Frank Kirchhoff;Thomas C. Greenough;John L. Sullivan

  • Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

    Katherine Luzuriaga;Yvonne J. Bryson;Paul A. Krogstad;James E. Robinson

  • Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses

    Katherine Luzuriaga;Margaret M. McManus;Michelle D. Catalina;Shane Renee Mayack

  • Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.

    Kitchen Lw;Barin F;Sullivan Jl;Sullivan Jl;McLane Mf

  • Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates

    Mark Mirochnick;Terry Fenton;Paul Gagnier;Joseph W. Pav

  • Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset

    Emily M. Mace;Emily M. Mace;Amy P. Hsu;Linda Monaco-Shawver;George Makedonas;George Makedonas

  • Activated lymphocytes during acute Epstein-Barr virus infection.

    Blake E. Tomkinson;David K. Wagner;David L. Nelson;John L. Sullivan

  • Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.

    Wenhui Li;Thomas C. Greenough;Michael J. Moore;Natalya Vasilieva

  • Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection

    Louis Alexander;Emma Weiskopf;Thomas C. Greenough;Nathan C. Gaddis

Frequent Co-Authors

Katherine Luzuriaga
Katherine Luzuriaga University of Massachusetts Chan Medical School
Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
Frank Kirchhoff
Frank Kirchhoff University of Ulm
Dennis Panicali
Dennis Panicali Harvard University
David T. Purtilo
David T. Purtilo University of Nebraska Medical Center
Richard D. Gelber
Richard D. Gelber Harvard University
Stephen A. Spector
Stephen A. Spector University of California, San Diego
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
David A. Thorley-Lawson
David A. Thorley-Lawson Tufts University
Liisa K. Selin
Liisa K. Selin University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your credentials through related healthcare degrees can open diverse career opportunities. Many professionals transition into advanced nursing roles that complement their scientific background. For instance, acute care nurse practitioner programs offer specialized training to provide high-level care in critical settings, important for immunocompromised patients.

If you are an RN aiming to fast-track your career, accelerated programs like those highlighted in accelerated RN to NP programs provide efficient pathways to becoming a Nurse Practitioner, allowing you to blend clinical expertise with immunology knowledge.

For individuals without a nursing background, the best route into the field might include starting with foundational qualifications. The best online BSN programs for non nurses are designed to equip students with essential nursing skills, ideal for integrating immunology concepts with patient care.

Additionally, many find that accelerated nursing programs offer accessible entry points into the nursing profession, allowing students to quickly gain credentials that support various immunology-related clinical roles.

Best Scientists Citing John L. Sullivan

Trending Scientists

Recently Published Articles